 |
Beckman Coulter drug discovery systems provide the proven technology.
Beckman Coulter, Inc. is devoted to increasing the speed and accuracy of the drug discovery process by providing instrument platforms that automate and streamline the processes from target identification through screening and
pharmacogenomics. Our products range from liquid handlers -- the BiomekŪ FX and
Biomek 2000 series -- to integrated automated systems for primary screening
--SAGIAN Core Systems. We provide products that feature unsurpassed software interfaces for easy and powerful instrument control, configurations that can easily be adapted to changing laboratory needs, and "smart solutions" that combine hardware, software, and chemistry validated together for specific applications such as nucleic acid preparation. This solid technology backed by superior support helps our customers reduce the time it takes therapeutics to go through the drug discovery process.
|
